Azoulay Salomon has filed 11 insider transactions across 1 company since September 2024.
Most recent transaction: a option exercise of 15003 shares of MBX Biosciences, Inc. ($MBX) on May 08, 2026.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 8, 2026 | MBX Biosciences, Inc. | $MBX | Azoulay Salomon | Chief Medical Officer | M | Stock option (right to buy) | 15003 | $0.00 | 30,008.0000 | 44,902,302 | 99.99% | 0.03% |
| May 8, 2026 | MBX Biosciences, Inc. | $MBX | Azoulay Salomon | Chief Medical Officer | M | Common Stock | 55000 | $10.46 | 69,769.0000 | 44,902,302 | 372.40% | 0.12% |
| May 8, 2026 | MBX Biosciences, Inc. | $MBX | Azoulay Salomon | Chief Medical Officer | S | Common Stock | 55000 | $38.38 | 14,769.0000 | 44,902,302 | 78.83% | 0.12% |
| May 8, 2026 | MBX Biosciences, Inc. | $MBX | Azoulay Salomon | Chief Medical Officer | M | Common Stock | 15003 | $16.00 | 29,772.0000 | 44,902,302 | 101.58% | 0.03% |
| May 8, 2026 | MBX Biosciences, Inc. | $MBX | Azoulay Salomon | Chief Medical Officer | S | Common Stock | 15003 | $38.30 | 14,769.0000 | 44,902,302 | 50.39% | 0.03% |
| May 8, 2026 | MBX Biosciences, Inc. | $MBX | Azoulay Salomon | Chief Medical Officer | M | Stock option (right to buy) | 55000 | $0.00 | 194,540.0000 | 44,902,302 | 39.42% | 0.12% |
| May 6, 2026 | MBX Biosciences, Inc. | $MBX | Azoulay Salomon | Chief Medical Officer | S | Common Stock | 231 | $29.54 | 14,769.0000 | 44,902,302 | 1.54% | 0.00% |
| Feb. 2, 2026 | MBX Biosciences, Inc. | $MBX | Azoulay Salomon | Chief Medical Officer | A | Common Stock | 15000 | $0.00 | 15,000.0000 | 44,902,302 | 9999.99% | 0.03% |
| Feb. 2, 2026 | MBX Biosciences, Inc. | $MBX | Azoulay Salomon | Chief Medical Officer | A | Stock option (right to buy) | 70000 | $0.00 | 70,000.0000 | 44,902,302 | 9999.99% | 0.16% |
| Feb. 3, 2025 | MBX Biosciences, Inc. | $MBX | Azoulay Salomon | Chief Medical Officer | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 12, 2024 | MBX Biosciences, Inc. | $MBX | Azoulay Salomon | Chief Medical Officer | A | Stock Option (Right to Buy) | 45011 | $0.00 | 45,011.0000 | 0 | 9999.99% | 0.00% |